ArticleMicrosystems & nanoengineering2026
Microcapillary-assisted acoustoelectric platform for selective single-cell isolation and in situ transfection.
Article in Microsystems & nanoengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Single-cell transfection technologies hold tremendous promise for precision cell and immunotherapies. However, monolithic integration of cell isolation with targeted intracellular delivery remains technically challenging, especially within complex biological matrices. Herein, we present a microcapillary-assisted acoustoelectric single-cell selective isolation and sonoporative transfection platform (μC-ASSIST), which seamlessly sequences microcapillary-assisted dielectrophoresis (μC-DEP) for deterministic single-cell trapping with high-frequency surface acoustic waves (SAWs) for transient membrane poration within a unified workflow. We demonstrate the label-free, high-efficiency extraction of human non-small cell lung cancer (A549) cells from a complex white blood cell (WBC) background with a capture efficiency of 95%. Furthermore, we validate the highly efficient, contact-free intracellular delivery of diverse cargoes ranging from small dyes (PI) to functional small interfering RNA (siRNA) and large plasmid DNA (mRFP-C3), maintaining a high cell viability of 83.7% alongside a 78.1% transfection efficiency. Crucially, the targeted delivery of siBcl-xL significantly suppressed target mRNA expression and profoundly inhibited tumor cell motility. By circumventing off-target effects and cumbersome manual handling, the μC-ASSIST platform establishes a highly versatile, streamlined paradigm for precision single-cell engineering, holding immense potential for advancing functional genomics and next-generation gene therapies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.